Form 10-Q Minerva Neurosciences, For: Sep 30
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/17/2026
- Generac strikes $8B supply deal with Amazon for data center power
- Wall St ends lower after Fed hikes interest rates, sees more tightening ahead
- Paradium AI (PAAI) Halted, News Pending
- Shipping stocks on fire — but cracks are forming in the rate rally
- JPMorgan Fed scenario analysis: 5 paths for the S&P 500 today
Minerva Neurosciences (NERV) Misses Q3 EPS by 3c
November 3, 2016 8:42 AM EDTMinerva Neurosciences (NASDAQ: NERV) reported Q3 EPS of ($0.24), $0.03 worse than the analyst estimate of ($0.21).
Cash, cash equivalents and marketable securities as of September 30, 2016 were approximately $91.9 million, compared to $32.2 million as of December 31, 2015. As previously stated, Minerva expects that its cash, cash equivalents and... More

